Learning objectives: Type I hypersensitivity reactions uniquely involve the
IgE class of immunoglobulins (Ig). IgE differs from other classes of Ig in
that the majority of the antibodies are bound to high affinity IgE Fc epsi
lon Rs that are expressed on a variety of cell types. Some of these cell ty
pes, most notably, mast cells and basophils, are triggered to undergo rapid
activation, degranulation, and release of bioactive mediators following bi
nding of antigen to Fc epsilon RI-bound IgE. Because of the central role th
at IgE antibodies and these mediators play in the tissue injury typical of
type I hypersensitivity, this article will review the Various stages of B l
ymphocyte development, activation, and differentiation and comment, where a
ppropriate on potential sites of deregulation in allergic disease.
Data sources: A literature search of the stages of B lymphocyte differentia
tion with emphasis on events that concern IgE expression was performed.
Results: B lymphocyte differentiation into IgE expressing cells is dependen
t upon three types of signals. The first signal is delivered through the B
cell antigen receptor and is pivotal in determining the antigenic specifici
ty of the response. The second signal is provided primarily by cytokines de
rived from T helper 2 (TH2) cells, ie, interleukin (IL)-4 and IL-13. These
cytokines are under tight regulation and their role appears to be the stimu
lation of transcription through the Ig constant region genes. Finally, the
third signal is provided via the interaction between the constitutively exp
ressed CD40 molecule on B lymphocytes and CD154 (CD40 ligand), a molecule e
xpressed on T lymphocytes following activation. Elevated levels of IgE in a
topic individuals may result from the preferential activation of TH2 cells.
Conclusions: A greater understanding of the regulation of IgE expression ma
y be central to the development of more effective immunotherapy strategies
designed to attenuate IgE synthesis.